Clinical Radiology
Volume 63, Issue 5 , Pages 557-561 , May 2008

Transrectal ultrasound-guided biopsy of the prostate: aspirin increases the incidence of minor bleeding complications

  • O.T. Halliwell

      Affiliations

    • Department of Radiology, Southampton General Hospital, Southampton, UK
    • Corresponding Author InformationGuarantor and correspondent: O. Halliwell, Department of Diagnostic Imaging, Peter Lougheed Center, 3500 26th Avenue NE, Calgary, Canada T1Y 6J4. Tel./fax: +1 403 9434570.
    • ,
  • G. Yadegafar

      Affiliations

    • Public Health Sciences and Medical Statistics Division, School of Medicine, Southampton General Hospital, Southampton University, Southampton, UK
    • ,
  • C. Lane

      Affiliations

    • Department of Radiology, Southampton General Hospital, Southampton, UK
    • ,
  • K.C. Dewbury

      Affiliations

    • Department of Radiology, Southampton General Hospital, Southampton, UK

Received 10 February 2007 ,Revised 21 September 2007 ,Accepted 24 September 2007.

References 

  1. Ghani KR, Dundas D, Patel U. Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol. BJU Int. 2004;94:1014–1020
  2. Connor SEJ, Wingate JP. Management of patients treated with aspirin or warfarin and evaluation of haemostasis prior to prostatic biopsy: a survey of current practice amongst radiologists and urologists. Clin Radiol. 1999;54:598–603
  3. Herget EJ, Saliken MD, Donnelly BJ, et al. Transrectal ultrasound-guided biopsy of the prostate: relation between ASA use and bleeding complications. Can Assoc Radiol J. 1999;50:173–176
  4. Maan Z, Cutting CW, Patel U, et al. Morbidity of transrectal US-guided prostate biopsies in patients after the continued use of low-dose aspirin. BJU Int. 2003;91:798–800
  5. Rodriguez LV, Terris MK. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol. 1998;160:2115–2120
  6. Beving H, Zhao C, Albage A, et al. Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coagul Fibrinolysis. 1996;7:80–84
  7. Fatah K, Beving H, Albage A, et al. Acetylsalicylic acid may protect the patient by increasing the fibrin gel porosity. Is withdrawal of treatment harmful to the patient?. Eur Heart J. 1996;17:1362–1366
  8. Vial JH, McLeod LJ, Roberts MS. Rebound elevation in urinary thromboxane B2 and 6-keto-PGF1 alpha excretion after aspirin withdrawal. Adv Prostaglandin Thromboxane Leukot Res. 1991;21A:157–160
  9. Collet JP, Himbet F, Steg PG. Myocardial infarction after aspirin cessation in stable coronary artery disease patients. Int J Cardiol. 2000;76:257–258
  10. Ferrari E, Benhamou M, Cerboni P, et al. Coronary syndromes following aspirin withdrawal. Chest. 2003;124(Suppl.):148S
  11. Albaladejo P, Geeraerts T, Francis F, et al. Aspirin withdrawal and acute lower limb ischemia. Anesth Analg. 2004;99:440–443
  12. Burger W, Chemnitius GD, Kneissl GD, et al. Low-dose aspirin for secondary cardiovascular prevention – cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation. Review and meta-analysis. J Intern Med. 2005;257:399–414

PII: S0009-9260(07)00468-0

doi: 10.1016/j.crad.2007.09.014

Clinical Radiology
Volume 63, Issue 5 , Pages 557-561 , May 2008

Article Tools